Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
5.09
-0.10 (-1.93%)
Sep 16, 2025, 4:00 PM EDT - Market closed
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $18.59 million as of September 17, 2025. Its market cap has increased by 143.54% in one year.
Market Cap
18.59M
Enterprise Value
12.77M
1-Year Change
143.54%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $18.59M, a decrease of -88.79%. That is a compound annual growth rate of -19.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 18.59M | -27.08% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | 40.94M | 138.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |